Artemis Medicare Services Ltd

Artemis Medicare Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Artemis Medicare Services Ltd

₹ 245 2.46%
01 Aug - close price
artemishospitals.com BSE: 542919 NSE: ARTEMISMED
About

Artemis Medicare Services Ltd (AMSL) was incorporated on 2004, by the promoters of the Apollo Tyres Group, is engaged in healthcare business. AMSL operates a 541-bedded multi-specialty tertiary care hospital in Gurgaon. The specialty areas for AMSL include Orthopaedics, Oncology, Cardiovascular, Neurosciences and Bariatric & Minimally Invasive Surgery. ASML has been awarded with the NABH and JCI accreditation. AMSL has also diversified its presence through Artemis Daffodil , Artemis Lite, Artemis Cardiac Care and Artemis Solace models. [1][2]

Key Points

Geographical Revenue Break-up 9MFY24:[1]
Domestic : ~76%
Outside India : ~24%

Website BSE NSE
  • Market Cap ₹ 3,403 Cr.
  • Current Price ₹ 245
  • High / Low ₹ 350 / 208
  • Stock P/E 40.7
  • Book Value ₹ 61.2
  • Dividend Yield 0.18 %
  • ROCE 14.9 %
  • ROE 12.9 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company has delivered good profit growth of 32.5% CAGR over last 5 years

Cons

  • Stock is trading at 4.00 times its book value
  • Promoter holding has decreased over last quarter: -0.64%
  • Company has a low return on equity of 11.7% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Part of BSE Healthcare BSE SmallCap BSE Allcap

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
146 163 182 181 187 201 217 210 217 217 235 227 235
129 144 158 156 163 174 184 179 181 181 193 190 199
Operating Profit 17 19 24 26 25 27 33 32 36 36 42 37 36
OPM % 12% 12% 13% 14% 13% 14% 15% 15% 17% 16% 18% 16% 15%
1 2 1 1 2 1 2 2 2 4 8 9 12
Interest 4 4 5 5 5 6 7 8 8 8 8 8 8
Depreciation 6 6 7 8 8 9 9 10 10 10 11 11 11
Profit before tax 8 11 14 14 14 13 19 16 19 22 31 27 29
Tax % -57% 22% 31% 23% 23% 26% 27% 29% 28% 24% 27% 23% 20%
13 9 10 11 10 10 14 12 14 17 23 21 23
EPS in Rs 1.01 0.65 0.73 0.80 0.78 0.73 1.01 0.85 1.02 1.24 1.64 1.51 1.69
Raw PDF
Upcoming result date: 5 August 2025

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
261 368 402 459 503 547 563 402 545 714 845 913
234 325 359 406 442 480 501 367 477 620 717 763
Operating Profit 27 43 43 53 60 66 62 35 68 94 128 150
OPM % 11% 12% 11% 11% 12% 12% 11% 9% 12% 13% 15% 16%
1 3 5 4 3 2 4 7 3 7 7 33
Interest 13 12 9 9 9 11 13 12 11 19 30 30
Depreciation 9 12 12 15 18 20 22 21 21 29 38 43
Profit before tax 7 21 27 32 35 37 32 9 39 53 68 109
Tax % 0% 12% 21% 16% 24% 44% 36% 20% 16% 25% 28% 24%
7 19 22 27 27 21 20 7 33 40 49 83
EPS in Rs 0.32 0.88 1.03 1.29 1.27 0.98 1.54 0.54 2.46 2.96 3.62 6.07
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 15% 12% 7%
Compounded Sales Growth
10 Years: 10%
5 Years: 10%
3 Years: 19%
TTM: 8%
Compounded Profit Growth
10 Years: 16%
5 Years: 32%
3 Years: 36%
TTM: 71%
Stock Price CAGR
10 Years: %
5 Years: 70%
3 Years: 68%
1 Year: -8%
Return on Equity
10 Years: 10%
5 Years: 10%
3 Years: 12%
Last Year: 13%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 21 21 21 21 21 0.00 13 13 13 13 14 14
Reserves 116 135 163 183 210 280 301 308 348 393 438 828
110 85 68 94 91 114 108 137 190 268 305 280
66 90 93 124 130 160 159 130 145 207 191 221
Total Liabilities 313 331 345 422 452 555 581 589 697 882 948 1,343
236 239 249 283 309 381 387 372 476 584 699 729
CWIP 0 0 1 27 43 49 56 81 64 95 33 40
Investments 0 0 0 0 0 0 2 4 6 12 15 15
77 91 94 112 100 124 137 132 152 192 200 559
Total Assets 313 331 345 422 452 555 581 589 697 882 948 1,343

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
45 53 20 58 72 41 56 27 61 129 108 139
-12 -10 -14 -74 -67 -50 -22 -34 -106 -153 -90 -388
-21 -35 -24 19 -10 14 -33 13 44 30 -26 277
Net Cash Flow 11 7 -18 3 -4 5 2 6 -2 7 -8 28

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 41 39 49 48 40 52 50 48 47 43 36 37
Inventory Days 26 26 21 19
Days Payable 237 195 189 187
Cash Conversion Cycle -171 -129 -120 -120 40 52 50 48 47 43 36 37
Working Capital Days -70 -59 -31 -44 -53 -51 -36 -35 -25 -45 -29 -29
ROCE % 8% 14% 15% 16% 15% 14% 11% 4% 10% 11% 14% 15%

Shareholding Pattern

Numbers in percentages

Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025
69.27% 68.91% 68.91% 68.03% 68.03% 68.03% 68.03% 67.51% 67.17% 67.17% 67.17% 66.53%
0.00% 0.00% 0.00% 0.07% 0.09% 0.11% 0.10% 0.16% 0.21% 0.65% 0.31% 0.24%
0.90% 1.15% 1.37% 1.41% 1.51% 1.96% 2.61% 3.45% 3.60% 4.51% 5.04% 4.76%
7.31% 7.27% 7.27% 7.18% 7.18% 7.18% 7.18% 7.12% 7.09% 7.09% 7.09% 7.02%
22.53% 22.65% 22.43% 23.30% 23.18% 22.72% 22.08% 21.76% 21.93% 20.59% 20.39% 21.45%
No. of Shareholders 14,63717,99518,10019,08220,52922,37519,99319,79526,05427,00428,39731,614

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls

  • May 2025
    Transcript
    Notes
    PPT
  • Feb 2025
    Transcript
    Notes
    PPT
  • Nov 2024
    Transcript
    Notes
    PPT
  • Aug 2024
    Transcript
    Notes
    PPT
  • May 2024
    Transcript
    Notes
    PPT
  • Feb 2024
    Transcript
    Notes
    PPT
  • Feb 2024
    Transcript
    Notes
    PPT
  • Nov 2023
    Transcript
    Notes
    PPT
  • Aug 2023
    Transcript
    Notes
    PPT
  • May 2023
    Transcript
    Notes
    PPT
  • Feb 2023
    Transcript
    Notes
    PPT
  • Nov 2022
    Transcript
    Notes
    PPT